160 related articles for article (PubMed ID: 7173449)
1. Stimulation of non-specific resistance and specific immune response against tumours in mice by synthetic muramyl dipeptide.
Nĕmecková S; Bubeník J; Jezek J; Zaoral M
Folia Biol (Praha); 1982; 28(5):327-33. PubMed ID: 7173449
[TBL] [Abstract][Full Text] [Related]
2. [Activation of the production of the tumor-necrosis factor by the combined action of lipopolysaccharide and muramyl dipeptide in vitro and in vivo].
Fuks BB; Rakhmilevich AL; Pimenov AA; Dubrovskaia AG
Biull Eksp Biol Med; 1987 Oct; 104(10):497-9. PubMed ID: 3315036
[TBL] [Abstract][Full Text] [Related]
3. The test of non-specific cell-mediated response in animals with transplantable tumours stimulated with calf thymus extract.
Jaszcz W; Chłap Z; Rzepecki W; Szot W; Piotrowska K
Acta Physiol Pol; 1983; 34(1):67-75. PubMed ID: 6637532
[TBL] [Abstract][Full Text] [Related]
4. [The synergistic action of lipopolysaccharide and muramyl dipeptide in the immunotherapy of DBA/2 mice with mastocytoma P815].
Rakhmilevich AL; Rakhimova MS
Biull Eksp Biol Med; 1989 Dec; 108(12):721-4. PubMed ID: 2517487
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of tumor growth in mice treated with synthetic muramyl dipeptide.
Bubeník J; Jezek J; Zaoral M; Hofmann J; Gruntenko YV; Osipov JG; Zolotareva AG; Vakhrusheva TE; Budker VG
Cancer Immunol Immunother; 1984; 18(2):123-5. PubMed ID: 6568871
[TBL] [Abstract][Full Text] [Related]
6. Opposite effects of the synthetic immunomodulator, muramyl dipeptide, on rejection of mouse skin allografts.
Zídek Z; Capková J; Boubelík M; Masek K
Eur J Immunol; 1983 Oct; 13(10):859-61. PubMed ID: 6357810
[TBL] [Abstract][Full Text] [Related]
7. Muramyl dipeptide analogues as potentiators of the antitumor action of endotoxin.
Bloksma N; Hofhuis FM; Willers JM
Cancer Immunol Immunother; 1985; 19(3):205-10. PubMed ID: 3847290
[TBL] [Abstract][Full Text] [Related]
8. Endotoxin-induced antitumor activity in the mouse is highly potentiated by muramyl dipeptide.
Bloksma N; Hofhuis FM; Willers JM
Cancer Lett; 1984 Jun; 23(2):159-65. PubMed ID: 6378362
[TBL] [Abstract][Full Text] [Related]
9. Dissociation between tumour resistance and delayed-type hypersensitivity to tumour-associated antigens in the mouse.
Henderson DC; Parker D; Turk JL
Immunology; 1980 Jan; 39(1):1-9. PubMed ID: 7380461
[TBL] [Abstract][Full Text] [Related]
10. Specific desensitization of resistance against a syngeneic methylcholanthrene-induced sarcoma in C3Hf mice.
Vaage J
Cancer Res; 1972 Feb; 32(2):193-9. PubMed ID: 5058179
[No Abstract] [Full Text] [Related]
11. Macrophages and resistance to tumours: influence of agents affecting macrophages and delayed-type hypersensitivity on resistance to tumours inducing concomitant immunity.
Nelson M; Nelson DS
Aust J Exp Biol Med Sci; 1978 Apr; 56(2):211-23. PubMed ID: 209776
[TBL] [Abstract][Full Text] [Related]
12. Modulation of anti-tumour immunity and the effect of bacterial endotoxin on the growth of different syngeneic tumours from small inocula in mice.
Kearney R; Harrop P
Br J Exp Pathol; 1986 Jun; 67(3):371-81. PubMed ID: 3521708
[TBL] [Abstract][Full Text] [Related]
13. B30-MDP, a synthetic muramyl dipeptide derivative for tumour vaccination to enhance antitumour immunity and antimetastatic effect in mice.
Yoo YC; Saiki I; Sato K; Azuma I
Vaccine; 1992; 10(11):792-7. PubMed ID: 1441733
[TBL] [Abstract][Full Text] [Related]
14. Castration effects on tumor-specific immunity.
Brannen GE
Natl Cancer Inst Monogr; 1978 Dec; (49):101-4. PubMed ID: 748764
[TBL] [Abstract][Full Text] [Related]
15. Concomitant immunity and specific depression of immunity by residual or reinjected syngeneic tumor tissue.
Vaage J
Cancer Res; 1971 Nov; 31(11):1655-62. PubMed ID: 5121668
[No Abstract] [Full Text] [Related]
16. Vascular clearance of embolic tumor cells and colloidal carbon and the levels of serum lysozyme following muramyl dipeptide administration.
Proctor JW; Waters RV; Jones GH; Gorecka-Tisera A; Yamamura Y
Oncodev Biol Med; 1982; 3(2-3):179-90. PubMed ID: 7122255
[TBL] [Abstract][Full Text] [Related]
17. Concomitant immunity and specific desensitization in murine tumor hosts.
Vaage J
Isr J Med Sci; 1973 Mar; 9(3):332-43. PubMed ID: 4710041
[No Abstract] [Full Text] [Related]
18. [Effect of novel derivatives of muramyl dipeptide on the immune system].
Kaliuzhin OV; Fuks BB; Bovin NV; Zemliakov AE; Chirva VIa
Biull Eksp Biol Med; 1994 May; 117(5):510-3. PubMed ID: 9296705
[No Abstract] [Full Text] [Related]
19. Tumor immunity in vivo: evidence that immune destruction of tumor leaves "bystander" cells intact.
Weissman IL
J Natl Cancer Inst; 1973 Aug; 51(2):443-8. PubMed ID: 4765368
[No Abstract] [Full Text] [Related]
20. [Participation of the dopaminergic system in the immune response-stimulating effect of muramyl dipeptide].
Al'perina EL; Zidek Z; Idova GV; Devoĭno LV
Biull Eksp Biol Med; 1988 Aug; 106(8):198-200. PubMed ID: 3416056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
